scholarly journals A Case Report of Isolated Cuboid Nutcracker Fracture

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Takaaki Ohmori ◽  
Shinichi Katsuo ◽  
Chiaki Sunayama ◽  
Katsunori Mizuno ◽  
Tomohiro Ojima ◽  
...  
Keyword(s):  
Bone Biopsy ◽  
Treatment Plan ◽  
Joint Surface ◽  
Artificial Bone ◽  
Lisfranc Joint ◽  
Large Defect ◽  
Biopsy Needle ◽  
Lateral Column ◽  
Surgery Patient ◽  
New Treatment

Isolated cuboid fractures are very rare, since they typically occur in combination with midfoot fractures or dislocations. A 61-year-old man presented at our hospital with pain and swelling on the outside of his right foot. The lateral column of his right foot was shortened by approximately 6.5 mm on X-ray. CT showed displacement of the joint surface between the cuboid and the fourth metatarsal, with a 3.5 mm depression. An MRI revealed no other injuries. Based on these findings, we diagnosed the patient with an isolated nutcracker fracture of the cuboid. Using a 1.9 mm arthroscope, we examined the Lisfranc joint. Then the depressed fragments were elevated until the regular joint line was restored. A bone biopsy needle was then used to fill in the large defect with artificial bone. In this case, we did not plate the fracture. Six months after surgery, patient could walk without pain. We report a very rare case of isolated nutcracker fracture of the cuboid. In addition, we suggest our new treatment plan of this fracture.

Recent Updates in Both the Diagnosis and Treatment Options that Impact the Clinical Treatment of Pulmonary Arterial Hypertension

2010 ◽  
Vol 2 ◽  
pp. CMT.S4192
Author(s):  
Charles D. Burger
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Treatment Plan ◽  
Treatment Options ◽  
Pharmaceutical Formulations ◽  
World Health ◽  
New Agents ◽  
Pulmonary Arterial ◽  
New Treatment ◽  
Health Organization

The evaluation and management of pulmonary arterial hypertension (PAH) is a rapidly evolving area of subspecialty medicine requiring regular clinical updates. Most notably are changes in the World Health Organization diagnostic scheme whereby the clinician categorizes the correct type of pulmonary hypertension in order direct the most specific evaluation and treatment plan. In addition, there have been several changes in both the FDA-approved pharmaceutical formulations and new agents for the treatment of PAH. This review will provide an update in these areas and more importantly, guidance to the clinician on the most appropriate utilization of these new treatment options.

scholarly journals Osteoarthritis of Lateral Lisfranc Joint After Lateral Column Lengthening in Flatfoot

2016 ◽  
Vol 1 (1) ◽  
pp. 2473011416S0006
Author(s):  
Yasuhisa Yoshida ◽  
Hidenori Matsubara ◽  
Takao Aikawa ◽  
Shuhei Ugaji ◽  
Hiroyuki Tsuchiya
Keyword(s):  
Lisfranc Joint ◽  
Lateral Column ◽  
Lateral Column Lengthening

The role of staging laparotomy in combined modality therapy of Hodgkin's disease: A new treatment plan based on a 6-year experience

1978 ◽  
Vol 2 (1) ◽  
pp. 101-105 ◽  
Author(s):  
Richard E. Wilson ◽  
Robert T. Osteen ◽  
David S. Rosenthal ◽  
Peter M. Mauch ◽  
Robert L. Goodman
Keyword(s):  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Treatment Plan ◽  
Combined Modality Therapy ◽  
Staging Laparotomy ◽  
Combined Modality ◽  
New Treatment

scholarly journals Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19

2021 ◽  
Vol 8 ◽  
Author(s):  
Yingning Li ◽  
Zhen Wang ◽  
Naqi Lian ◽  
Yuzun Wang ◽  
Weiqiang Zheng ◽  
...  
Keyword(s):  
Molecular Hydrogen ◽  
Treatment Plan ◽  
Inflammatory Cells ◽  
Therapeutic Effects ◽  
Mixed Gas ◽  
Pathophysiological Process ◽  
International Attention ◽  
New Treatment ◽  
Underlying Mechanisms ◽  
Excessive Inflammatory Response

Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19.

scholarly journals Treatment of alcohol dependence

2012 ◽  
pp. 447-459
Author(s):  
Jonathan Chick
Keyword(s):  
Alcohol Dependence ◽  
Treatment Plan ◽  
Strong Predictor ◽  
Continuous Treatment ◽  
Improve Compliance ◽  
Rational Thought ◽  
Therapist Influence ◽  
New Treatment ◽  
Set Up ◽  
Will Power

Some people repeatedly put themselves or others at risk by drinking. One view is that such people could drink sensibly if they were more considerate and used more will power. Another increasingly accepted view is that many such individuals are in a state, existing in degrees of severity, in which the freedom to decide whether to change their drinking, and to adhere to that decision, is reduced compared with other drinkers. This state partly depends on perceived pay-offs for changing, and on acquired dispositions, which are less accessible to conscious control. Such persons become aware of a wish, or urge, to drink, which overcomes rational thought. They may then make up an explanation, for example, ‘No wonder I feel like a drink, I've had a hard day’. Such individuals benefit from help to unlearn those patterns, and to learn different approaches to problems. Discussion, care, and encouragement from others can bolster their will to do so. Assistance to set-up controls within or from outside themselves may help. Some people can do this without external help, and others with the help of Alcoholics Anonymous (AA) alone. This approach argues that dependence on alcohol should be managed like other relapsing disorders, such as diabetes and asthma, by using long-term monitoring coupled with intermittent or continuous treatment. Research into alcoholism spanning 50 years has shown that the attitudes of the agency and the therapist influence patients’ outcome, as they may do for many illnesses. The therapeutic alliance is a strong predictor of outcome in the treatment of alcohol dependence. However, agencies must also be prepared to set limits on drunken behaviour at the clinic and telephone calls when intoxicated. And for patients who repeatedly relapse, resumption of treatment should sometimes be made conditional on complying with a new treatment plan, such as supervision of medication. Showing respect, enhancing dignity, conveying accurate empathy, adopting objective and not moral criteria, involving the family, and reducing hurdles to seeking help have been shown to improve compliance, and often outcome, for alcohol dependence.

Sign in / Sign up

Export Citation Format

Share Document